A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension
NCT00430638
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
278
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
olmesartan medoxomil + hydrochlorothiazide, if necessary
DRUG:
Placebo
Sponsor
Daiichi Sankyo